Found: 36
Select item for more details and to access through your institution.
The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7865, doi. 10.3390/ijms23147865
- By:
- Publication type:
- Article
Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC).
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 11, p. 1808, doi. 10.3390/cells11111808
- By:
- Publication type:
- Article
Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11472, doi. 10.3390/ijms222111472
- By:
- Publication type:
- Article
Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3793, doi. 10.3390/cancers13153793
- By:
- Publication type:
- Article
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1137, doi. 10.3390/cancers13051137
- By:
- Publication type:
- Article
Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 200, doi. 10.1016/j.clcc.2020.02.012
- By:
- Publication type:
- Article
Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin.
- Published in:
- Marine Drugs, 2020, v. 18, n. 4, p. 191, doi. 10.3390/md18040191
- By:
- Publication type:
- Article
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 832, doi. 10.3390/cancers11060832
- By:
- Publication type:
- Article
Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 441, doi. 10.3390/cells8050441
- By:
- Publication type:
- Article
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first-line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1433, doi. 10.3892/ijo.2019.4709
- By:
- Publication type:
- Article
Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.
- Published in:
- Stem Cells Translational Medicine, 2019, v. 8, n. 3, p. 285, doi. 10.1002/sctm.18-0117
- By:
- Publication type:
- Article
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study.
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1372, doi. 10.1634/theoncologist.2017-0530
- By:
- Publication type:
- Article
Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2018, v. 24, n. 4, p. 684, doi. 10.1177/1076029617715116
- By:
- Publication type:
- Article
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 6, p. 1747, doi. 10.3892/ijo.2017.4172
- By:
- Publication type:
- Article
Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 6, p. 1793, doi. 10.3892/ijo.2017.4170
- By:
- Publication type:
- Article
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1222, doi. 10.1634/theoncologist.2016-0414
- By:
- Publication type:
- Article
Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study.
- Published in:
- Thrombosis Journal, 2017, v. 15, p. 1, doi. 10.1186/s12959-017-0131-7
- By:
- Publication type:
- Article
The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2017, v. 23, n. 2, p. 155, doi. 10.1177/1076029616665922
- By:
- Publication type:
- Article
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 8, p. 1221, doi. 10.1016/j.molonc.2016.05.009
- By:
- Publication type:
- Article
Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Unique features of trabectedin mechanism of action.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 ( MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 4, p. 676, doi. 10.1002/cam4.635
- By:
- Publication type:
- Article
Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087878
- By:
- Publication type:
- Article
PARPs and the DNA damage response.
- Published in:
- Carcinogenesis, 2012, v. 33, n. 8, p. 1433, doi. 10.1093/carcin/bgs132
- By:
- Publication type:
- Article
In Vivo Topoisomerase I Inhibition Attenuates the Expression of Hypoxia-Inducible Factor 1α Target Genes and Decreases Tumor Angiogenesis.
- Published in:
- Molecular Medicine, 2012, v. 18, n. 1, p. 83, doi. 10.2119/molmed.2011.00120
- By:
- Publication type:
- Article
The evolution of adjuvant therapy in the treatment of early-stage colon cancer.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study.
- Published in:
- Oncologist, 2011, v. 16, n. 9, p. 1228, doi. 10.1634/theoncologist.2011-0039
- By:
- Publication type:
- Article
Targeted Therapies as Adjuvant Treatment for Early-Stage Colorectal Cancer: First Impressions and Clinical Questions.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 269, doi. 10.3816/CCC.2010.n.039
- By:
- Publication type:
- Article
5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line.
- Published in:
- Journal of Applied Toxicology, 2009, v. 29, n. 4, p. 308, doi. 10.1002/jat.1411
- By:
- Publication type:
- Article
Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305, a topoisomerase II inhibitor with antitumor activities.
- Published in:
- Nucleic Acids Research, 2005, v. 33, n. 18, p. 6034, doi. 10.1093/nar/gki904
- By:
- Publication type:
- Article
Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 4, p. 580, doi. 10.1002/(SICI)1097-0215(19990517)81:4<580::AID-IJC13>3.0.CO;2-T
- By:
- Publication type:
- Article
DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA.
- Published in:
- Journal of Cellular Biochemistry, 1998, v. 69, n. 2, p. 127, doi. 10.1002/(SICI)1097-4644(19980501)69:2<127::AID-JCB4>3.0.CO;2-U
- By:
- Publication type:
- Article
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function.
- Published in:
- Oncogene, 1997, v. 15, n. 23, p. 2817, doi. 10.1038/sj.onc.1201445
- By:
- Publication type:
- Article
Effect of Extracorporeal Enzymatic Deheparinization on Formed Blood Components.
- Published in:
- Artificial Organs, 1984, v. 8, n. 2, p. 198, doi. 10.1111/j.1525-1594.1984.tb04272.x
- By:
- Publication type:
- Article